Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids
- PMID: 32192594
- DOI: 10.1016/j.fertnstert.2019.10.028
Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids
Abstract
Objective: To compare long-term health-related quality of life (HRQOL) 1 year after hysterectomy or myomectomy for treatment of uterine fibroids (UFs) and to determine whether route of procedure, race, or age affected improvements in HRQOL.
Design: Prospective cohort study.
Setting: Eight clinical sites throughout the United States.
Patient(s): A total of 1,113 premenopausal women with UFs who underwent hysterectomy or myomectomy as part of Comparing Options for Management: Patient-Centered Results for Uterine Fibroids.
Intervention(s): None.
Main outcome measure (s): Self-reported HRQOL measures including Uterine Fibroid Symptom Quality of Life, the European QOL 5 Dimension Health Questionnaire, and the visual analog scale at baseline and 1-year after hysterectomy or myomectomy.
Result (s): Hysterectomy patients were older with a longer history of symptomatic UF compared with myomectomy patients. There were no differences in baseline HRQOL. After adjustment for baseline differences between groups, compared with myomectomy, patients' HRQOL (95% confidence interval [CI], 5.4, 17.2) and symptom severity (95% CI, -16.3, -8.8) were significantly improved with hysterectomy. When stratified across race/ethnicity and age, hysterectomy had higher HRQOL scores compared with myomectomy. There was little difference in HRQOL (95% CI, 0.1 [-9.5, 9.6]) or symptom severity (95% CI, -3.4 [-10, 3.2]) between abdominal hysterectomy and abdominal myomectomy.
Conclusion (s): HRQOL improved in all women 1 year after hysterectomy or myomectomy. Hysterectomy patients reported higher HRQOL summary scores compared with myomectomy patients. When stratified by route, minimally invasive hysterectomy had better HRQOL scores than minimally invasive myomectomy. There was little difference in scores with abdominal approaches.
Keywords: Hysterectomy; minimally invasive; myomectomy; quality of life; uterine fibroids.
Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
Does hysterectomy result in better quality of life than myomectomy?Fertil Steril. 2020 Mar;113(3):549-550. doi: 10.1016/j.fertnstert.2019.11.020. Epub 2020 Feb 25. Fertil Steril. 2020. PMID: 32111476 No abstract available.
Similar articles
-
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.Am J Obstet Gynecol. 2023 Sep;229(3):275.e1-275.e17. doi: 10.1016/j.ajog.2023.05.020. Epub 2023 May 26. Am J Obstet Gynecol. 2023. PMID: 37244458
-
Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas.Obstet Gynecol. 2019 Aug;134(2):261-269. doi: 10.1097/AOG.0000000000003354. Obstet Gynecol. 2019. PMID: 31306318 Free PMC article.
-
A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.Trials. 2014 Nov 29;15:468. doi: 10.1186/1745-6215-15-468. Trials. 2014. PMID: 25432688 Free PMC article. Clinical Trial.
-
Alternatives to hysterectomy: The burden of fibroids and the quality of life.Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:31-42. doi: 10.1016/j.bpobgyn.2017.10.001. Epub 2017 Oct 20. Best Pract Res Clin Obstet Gynaecol. 2018. PMID: 29157931 Review.
-
[Role of embolization in the management of uterine fibroids].J Gynecol Obstet Biol Reprod (Paris). 2011 Dec;40(8):918-27. doi: 10.1016/j.jgyn.2011.09.030. Epub 2011 Nov 16. J Gynecol Obstet Biol Reprod (Paris). 2011. PMID: 22093440 Review. French.
Cited by
-
Uterine fibroids and longitudinal profiles of the vaginal microbiota in a cohort presenting for transvaginal ultrasound.PLoS One. 2024 Feb 5;19(2):e0296346. doi: 10.1371/journal.pone.0296346. eCollection 2024. PLoS One. 2024. PMID: 38315688 Free PMC article.
-
Exploring Surgical Strategies for Uterine Fibroid Treatment: A Comprehensive Review of Literature on Open and Minimally Invasive Approaches.Medicina (Kaunas). 2023 Dec 28;60(1):64. doi: 10.3390/medicina60010064. Medicina (Kaunas). 2023. PMID: 38256325 Free PMC article. Review.
-
The impact of fibroid treatments on quality of life and mental health: a systematic review.Fertil Steril. 2024 Mar;121(3):400-425. doi: 10.1016/j.fertnstert.2024.01.021. Epub 2024 Jan 19. Fertil Steril. 2024. PMID: 38246400 Free PMC article. Review.
-
Care Delivery for Patients with Leiomyomas: Failures, Real-Life Experiences, Analysis of Barriers, and Proposed Restorative Remedies.Health Equity. 2023 Aug 25;7(1):439-452. doi: 10.1089/heq.2022.0116. eCollection 2023. Health Equity. 2023. PMID: 37638119 Free PMC article. Review.
-
Association between hysterectomy and hypertension among Indian middle-aged and older women: a cross-sectional study.BMJ Open. 2023 Apr 20;13(4):e070830. doi: 10.1136/bmjopen-2022-070830. BMJ Open. 2023. PMID: 37080618 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
